Bradley Patton
Family Medicine · Hudson, OHNPI 1255743787
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Novo Nordisk at 27.4% of the total. Reporting peaked in 2019 at $779 and has fallen 98.3% since, to $14 in 2023.
Across 82 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$331
- Astellas Pharma US Inc$164
- AbbVie$87
- Amgen$73
- Pfizer$71
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$70
- plus $410 from 14 others
What the payments were for
- Food & beverage$1,207100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $331 |
| Astellas Pharma US Inc | 11 | $164 |
| AbbVie | 6 | $87 |
| Amgen | 5 | $73 |
| Pfizer | 5 | $71 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $70 |
| Novartis | 4 | $69 |
| Johnson & Johnson | 4 | $51 |
| Amarin Pharma, Inc. | 3 | $44 |
| Currax Pharmaceuticals LLC | 3 | $39 |
| AstraZeneca | 3 | $36 |
| Gilead | 2 | $31 |
| Merck | 2 | $25 |
| Bausch Health US, LLC | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
How this compares
$1,207 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 12 | $210 |
| Atorvastatin Calcium | 11 | $95 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Hudson
- Jon TosinoHudson$22K
- Clayton SeipleHudson$20K
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.